Aducanumab, sold under the brand name Aduhelm, is used t...

wikipedia - 08 Jun 2021
Aducanumab, sold under the brand name Aduhelm, is used to treat Alzheimer's disease (AD). It is an amyloid beta-directed antibody.

Biogen discontinues Alzheimer’s medication Aduhelm

CNN - 31 Jan 2024
Biogen discontinues Alzheimer’s medication Aduhelm ...

Biogen terminates phase 4 efficacy study of aducanumab

UCI MIND - 31 Jan 2024
Biogen terminates phase 4 efficacy study of aducanumab ...

Biogen's Abandonment of AD Drug No Surprise, Experts Say

Medscape - 01 Feb 2024
Biogen's Abandonment of AD Drug No Surprise, Experts Say ...

Biogen Abandons Its Controversial Alzheimer's Drug Aduhelm

The New York Times - 31 Jan 2024
Biogen Abandons Its Controversial Alzheimer's Drug Aduhelm ...

Lessons Learned From Aducanumab Experience and Antiamyloid Therapies: Ian Kremer

Neurology Live - 23 Feb 2024
Lessons Learned From Aducanumab Experience and Antiamyloid Therapies: Ian Kremer ...

Controversial Alzheimer's Drug Abandoned

Medpage Today - 31 Jan 2024
Controversial Alzheimer's Drug Abandoned ...

Development and sale of Alzheimer's drug, aducanumab, ceased

Alzheimer's Research UK - 02 Feb 2024
Development and sale of Alzheimer's drug, aducanumab, ceased ...

Alzheimer's: Ultrasound gets aducanumab straight to the brain

Medical News Today - 19 Jan 2024
Alzheimer's: Ultrasound gets aducanumab straight to the brain ...

Poll: Are You Surprised by the Discontinuation of Aducanumab?

Psychiatric Times - 31 Jan 2024
Poll: Are You Surprised by the Discontinuation of Aducanumab? ...

One step back: Why the new Alzheimer's plaque-attack drugs don't work

Scope - 13 Mar 2024
One step back: Why the new Alzheimer's plaque-attack drugs don't work ...

Adieu, Aduhelm: Biogen pulls plug on controversial Alzheimer's drug

Association of Health Care Journalists - 05 Feb 2024
Adieu, Aduhelm: Biogen pulls plug on controversial Alzheimer's drug ...

What don't we know about an Alzheimer's drug side effect? - STAT

STAT - 28 Nov 2023
What don't we know about an Alzheimer's drug side effect? - STAT ...

Biogen drops Alzheimer's drug Aduhelm, ending a 17-year chapter

Reuters - 31 Jan 2024
Biogen drops Alzheimer's drug Aduhelm, ending a 17-year chapter ...

Alzheimer’s ‘breakthrough’ stalls: why a much-hyped drug is facing approval delays

The Guardian - 23 Mar 2024
Alzheimer’s ‘breakthrough’ stalls: why a much-hyped drug is facing approval delays ...

Biogen relying on success of Leqembi following discontinuation of Aduhelm

BioPharma-Reporter.com - 04 Mar 2024
Biogen relying on success of Leqembi following discontinuation of Aduhelm ...

Aduhelm's Goodbye: ENVISION Confirmatory Study To End In May, With BLA Withdrawal In November

Pink Sheet - 02 Feb 2024
Aduhelm's Goodbye: ENVISION Confirmatory Study To End In May, With BLA Withdrawal In November ...

Biogen Discontinues Aducanumab, CHMP Issues Negative Opinion on Ataluren, SRP-5051 Shines in MOMENTUM ...

Neurology Live - 03 Feb 2024
Biogen Discontinues Aducanumab, CHMP Issues Negative Opinion on Ataluren, SRP-5051 Shines in MOMENTUM ... ...

Opening Blood-Brain Barrier to Deliver Alzheimer's Drug Shows Promise

Medpage Today - 04 Jan 2024
Opening Blood-Brain Barrier to Deliver Alzheimer's Drug Shows Promise ...

The Biogen Aduhelm mess could happen again - STAT

STAT - 06 Feb 2024
The Biogen Aduhelm mess could happen again - STAT ...

Aducanumab